Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you recommend XRT to post-cystectomy bladder cancer patient with metastatic PA and mesenteric nodes?
Answer from: Radiation Oncologist at Community Practice
I would not as this would have outcome like metastatic disease and need systemic treatment as the mainstay of treatment.
Sign in or Register to read more
12776
Related Questions
How would you treat a patient with a post prostatectomy biochemical and pelvic nodal recurrence with a BLM mutation?
Would you treat someone following FLAME protocol for prostate cancer without fiducials if using daily CBCT?
How would you plan sequencing of an MRI-directed prostate nodule micro-boost when doing a sequential plan?
Are patients with MIBC and bladder neck involvement good candidates for bladder preservation with chemoradiation after maximal, but not complete, TURBT?
How do you manage PSA progression while a patient is on xofigo or pluvicto?
Why is there a benefit of ADT for high risk prostate cancer treated with radiation, yet no large trials describing benefit of adjuvant ADT after radical prostatectomy?
Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?
Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?
What adjuvant treatment would you offer a patient who underwent cystoprostatectomy for a muscle invasive bladder cancer and discovered to also have prostate cancer?
Why do the most recent NCCN guidelines (Version 4.2024, 05/17/24) omit the duration of ADT for high-risk prostate cancer patients?